Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Recurrence × Biopsy × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 7 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Pancreatic Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Breast Neoplasms, Male 2 Barrett Esophagus 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Tuberculosis 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Intraepithelial Neoplasia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 16 fludarabine 12 Cisplatin 11 Rituximab 9 Dexamethasone 9 Gemcitabine 8 Cytarabine 7 fludarabine phosphate 6 Paclitaxel 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6 Lenalidomide 6 Decitabine 6 Radiotherapy 5 Etoposide 5 Carboplatin 5 Bendamustine Hydrochloride 5 camrelizumab 4 apatinib 4 Valproic Acid 4 Thalidomide 4 Procarbazine 4 Oxaliplatin 4 Injections 4 Bortezomib 4 Antilymphocyte Serum 4 tislelizumab 3 pomalidomide 3 Vinorelbine 3 Vinblastine 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02613962 2020-02-17

MAPPYACTS

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡